Publication | Closed Access

Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period differentially affects breast milk beneficial microbiota in relation to mode of delivery

ProbioticDysbiosisMultistrain Probiotic ProductLactationMicrobiotaPerinatal PeriodMaternal HealthBreastfeedingMicrobiologyGut BarrierMicrobiomeProbioticsMedicinePublic HealthHuman Lactation